Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
07/2012
07/04/2012CN102548965A 取代酰胺化合物 Substituted amide compounds
07/04/2012CN102532044A 1,4-dioxo-2-(1-ethoxy)-3-hydroxymethyl-sulfaquinoxaline and preparation method and application thereof
07/04/2012CN102532043A 1-oxo-2-(1-hydroxyethyl)3-hydroxymethyl-quinoxaline and preparation method and application thereof
07/04/2012CN102532009A Compounds for inhibiting dipeptidyl peptidase, preparation method for compounds and application of compounds
07/04/2012CN101898982B Npy y5 antagonists
07/04/2012CN101817790B Ethylene diamine-modified elsinochrome A derivative and preparation method thereof
07/04/2012CN101544610B Ligustrazine salt
07/03/2012US8212048 Method of producing aromatic compound
07/03/2012US8212040 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
07/03/2012US8211921 Heterocyclic inhibitors of MEK and methods of use
07/03/2012US8211896 Aryl sulfonamides
07/03/2012US8211895 Capped pyrazinoylguanidine sodium channel blockers
07/03/2012US8211890 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
07/03/2012CA2538405C Novel compounds
07/03/2012CA2481192C Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias
06/2012
06/28/2012WO2012087889A2 Dna methylation inhibitors
06/28/2012WO2012087861A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
06/28/2012WO2012087784A1 Heterocyclic compounds and their uses
06/28/2012WO2012085745A1 Glucagon receptor modulators
06/28/2012WO2012085645A1 Polymorphs of 3-chloro-4[(2r)-2
06/28/2012WO2012085222A1 Novel phenazine derivatives and their use
06/28/2012WO2012022467A3 Novel benzoquinone derivatives and use thereof as modulators of mitochondrial function
06/28/2012US20120165343 Glucagon Receptor Modulators
06/28/2012US20120165318 Heterocyclic compounds for the inhibition of pask
06/28/2012US20120164186 Diketopiperazine Microparticles with Defined Specific Surface Areas
06/28/2012US20120161108 Tetrahydrotetraazapentacenes in thin-film transistors
06/28/2012CA2822767A1 Polymorphs of 3-chloro-4[(2r)-2-(4-chlorophenyl)-4-[(1r)-1-(4-cyanophenyl)ethyl]-1-piperazinyl]-benzonitrile, pharmaceutical compositions and method of use comprising said polymorphs, and a process for preparing them
06/28/2012CA2822590A1 Heterocyclic compounds and their uses
06/28/2012CA2822017A1 Glucagon receptor modulators
06/28/2012CA2818597A1 Quinoxalines and aza-quinoxalines as crth2 receptor modulators
06/27/2012EP2468732A1 1H-Quinazoline-2,4-diones
06/27/2012EP2074096B1 3-pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as hdl-cholesterol raising agents
06/27/2012EP1389611B1 20-hydroxyeicosatetraenoic acid production inhibitors
06/27/2012CN102516384A MLKL protein and application of MLKL protein as target point of cell necrosis inhibitor
06/27/2012CN102516240A Heteroaryl-ureas and their use as glucokinase activators
06/27/2012CN102516184A DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating a diabetes or an obesity
06/27/2012CN101941947B Synthesis method of 2-chloro-6-chloroquinoxaline
06/27/2012CN101790522B Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists
06/27/2012CN101563330B Benzoyl amino heterocyclyl compounds as glucokinase (glk) activators
06/26/2012US8207165 3,4-dihydro-2H-pyrazino[1,2-A]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
06/26/2012US8207163 Compositions, synthesis, and methods of using piperazine based antipsychotic agents
06/26/2012CA2635093C Derivatives of sulindac, use thereof and preparation thereof
06/21/2012WO2012082853A1 Neprilysin inhibitors
06/21/2012WO2012080144A1 Oxime compounds as hdl-cholesterol raising agents
06/21/2012WO2012079154A1 Selective estrogen receptor modulators
06/21/2012US20120157476 Oxime compounds
06/21/2012US20120157474 Methods of Identifying and Using General or Alternative Splicing Inhibitors
06/21/2012US20120157462 Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
06/21/2012US20120152150 Organic colouring agents and coloured polymer compositions with a high stability to weathering
06/21/2012CA2818627A1 Oxime compounds as hdl-cholesterol raising agents
06/21/2012CA2817368A1 Neprilysin inhibitors
06/20/2012EP2465860A1 Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound
06/20/2012EP2465852A1 Capped pyrazinoylguanidine sodium channel blockers
06/20/2012EP1745041B1 Quinoxaline inhibitors of the hedgehog signalling pathway
06/20/2012CN102500292A Preparation method of amino-containing energetic material graded microspheres
06/20/2012CN101463016B Method for synthesizing 2,6-dimethyl piperazine
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/19/2012US8202513 Aryl potassium channel blockers and uses thereof
06/19/2012CA2613303C An oxime derivative for use as a glucokinase activator
06/14/2012US20120149718 Amido Compounds
06/14/2012US20120146009 Novel compound, field-effective transistor, solar cell, method for producing said compound, field-effective transistor, and solar cell, composition for organic semiconductor layer, and composition for p-type semiconductor layer
06/13/2012EP2463278A1 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
06/13/2012EP1704145B1 Selective kinase inhibitors
06/13/2012EP1618087B1 Antibacterial agents
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012CN102498103A Pyrazine carboxamides as inhibitors of DGAT1
06/13/2012CN102491950A Quinoxaline derivative and preparation method thereof
06/12/2012US8198440 Phosphonic acid compounds as inhibitors of serine proteases
06/12/2012US8198286 Sodium channel blockers
06/07/2012WO2012074040A1 Buguanide derivative compound
06/07/2012US20120142923 Manufacture of 4-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1r,3s)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazine
06/06/2012EP2460798A2 Apaf-1 inhibitor compounds
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP2174934B1 Oxopyrazine derivative and herbicide
06/06/2012CN101869824B Flue gas desulfurizing agent and flue gas desulfurization method
06/06/2012CN101429167B Process for producing novel cadmium ion artificial antigen chelating agent
06/05/2012US8193199 Heterocyclic compounds and their uses
06/05/2012US8191802 Aerosol
05/2012
05/31/2012WO2012071414A2 Quinoxaline compounds and uses thereof
05/31/2012WO2012069852A1 Pharmaceutical compounds as inhibitors of sphingosine kinase
05/31/2012US20120135975 Substituted Esters as Cannabinoid-1 Receptor Modulators
05/31/2012US20120135968 Tetracycline Compounds
05/31/2012US20120134930 Pyrazine Derivatives for Bioconjugation
05/30/2012EP2456435A1 Heteroaryl benzamides, compositions and methods of use
05/30/2012EP1438302B1 New sulfonamide derivatives as d3-receptor ligands
05/30/2012CN101899012B Method for improving synthesis process of Acipimox
05/30/2012CN101511799B Cyclic amine compound
05/30/2012CN101460468B 2-pyrazinecarboxamide derivatives
05/30/2012CN101153026B Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
05/29/2012US8188277 Aromatic compounds for suppressing the generation of collagen
05/29/2012US8188269 Functionalized compositions for improved immobilization
05/29/2012US8188090 Naphthylacetic acids
05/29/2012US8188077 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
05/29/2012CA2555624C Thioamide compounds or salts thereof and cytokine production inhibitors containing the same
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/24/2012WO2012068327A1 Acid gas absorbent composition
05/24/2012WO2012065573A1 Nitrogen heterocyclic substituted benzoyl compound and use thereof
05/24/2012WO2011147881A3 Cyclic dipeptides as feedstuff additives
05/24/2012US20120129939 Polyamine inhibitors for the treatment and prevention of parkinson's disease
05/24/2012US20120128693 Cadherin-11 inhibitors and methods of use thereof
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 187